What is Immunocore’s role in the fight against devastating diseases?

Immunocore is a late-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies to treat a broad range of diseases including cancer, infection and autoimmune diseases.

Where is Immunocore located?

Immunocore’s principal offices are located at 92 Park Drive, Milton Park, Abindgon, Oxfordshire OX14 4RY, United Kingdom. The company also has offices at Six Tower Bridge, Suite 200, 181 Washington Street, Conshohocken, Pennsylvania 19428 and 2273 Research Boulevard, Suite 220, Rockville, Maryland 20850, United States.

Where is Immunocore’s common stock listed and what is the ticker symbol?

Immunocore is listed on the Nasdaq Global Market under the ticker symbol IMCR.

When did Immunocore go public?

Immunocore began trading common stock shares on the Nasdaq Global Market on February 5, 2021.

Where can I purchase shares of Immunocore?

To purchase Immunocore shares, you must have an account with a financial intermediary (bank, brokerage firm, online broker, etc.) and place your order through them.

When is the fiscal year-end for Immunocore?

Immunocore’s fiscal year-end is on December 31.

Who is Immunocore’s Registrar and how do I contact them?

Computershare Investor Services PLC
The Pavilions
Bridgewater Road
BS99 6ZY
Phone: 0370 703 0387

Who is Immunocore’s American Depository Share (“ADS”) bank?

Immunocore’s ADS bank is Citibank, N.A. located at 388 Greenwich Street, New York, New York 10013.

Who are Immunocore’s independent auditors?

Deloitte LLP
1 Station Square
Cambridge, CB1 2GA
United Kingdom

Who is Immunocore’s outside legal counsel?

Cooley LLP
55 Hudson Yards
New York, New York 10001